ATOS - Atossa Genetics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 518.61M
Enterprise Value 3-163.69k
Trailing P/E N/A
Forward P/E 1-1.55
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.99
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.01

Trading Information

Stock Price History

Beta (3Y Monthly) 4.37
52-Week Change 3-18.40%
S&P500 52-Week Change 36.04%
52 Week High 37.3900
52 Week Low 30.8000
50-Day Moving Average 32.2250
200-Day Moving Average 32.3101

Share Statistics

Avg Vol (3 month) 3809.12k
Avg Vol (10 day) 3146.35k
Shares Outstanding 59.12M
Float 9.1M
% Held by Insiders 10.31%
% Held by Institutions 18.70%
Shares Short (Jun 28, 2019) 4355.79k
Short Ratio (Jun 28, 2019) 40.42
Short % of Float (Jun 28, 2019) 43.92%
Short % of Shares Outstanding (Jun 28, 2019) 43.90%
Shares Short (prior month May 31, 2019) 4312.24k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 212/1
Last Split Date 3Apr 20, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-63.06%
Return on Equity (ttm)-109.90%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -13.57M
Net Income Avi to Common (ttm)-25.08M
Diluted EPS (ttm)-4.3670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.57M
Total Cash Per Share (mrq)2.14
Total Debt (mrq)88.1k
Total Debt/Equity (mrq)0.45
Current Ratio (mrq)13.94
Book Value Per Share (mrq)2.06

Cash Flow Statement

Operating Cash Flow (ttm)-8.72M
Levered Free Cash Flow (ttm)-3.79M